2cureX and pedoc Medical have signed an agreement by which pedoc Medical becomes the distributor of IndiTreat® products in Switzerland and Austria. Under the terms of the collaboration, pedoc Medical will promote IndiTreat® to oncology professionals, sign supply agreements with hospitals and manage the sample logistics between the hospitals and the 2cureX labs in Copenhagen. The combined population of Austria and Switzerland is more than 17.5 million people, and their healthcare systems are amongst the best in Europe.

According to Medtech Europe ­ the IVD medical technology industry association ­ the average IVD yearly expenditure per capita in the EU + UK + EFTA is 26.4 EUR. Switzerland with 61.1 EUR and Austria with 52.2 are by far the highest two countries in the ranking, followed by Luxembourg with 33.5 EUR. The agreement has been signed for an initial term of three years, with automatic renewal for successive terms. Sales impact of this agreement is expected to show in 2023.